1509927-60-9 Usage
Uses
Used in Pharmaceutical Industry:
(Z)-bis-(4-[1,3]-dioxolan-2-yl-phenyl)diazine is used as an active pharmaceutical ingredient for the development of new drugs targeting various medical conditions. Its unique structure allows for the potential modulation of biological pathways and interactions with specific receptors, making it a promising candidate for drug discovery and development.
Used in Chemical Synthesis:
In the field of chemical synthesis, (Z)-bis-(4-[1,3]-dioxolan-2-yl-phenyl)diazine serves as a key intermediate or building block for the creation of more complex molecules with specific functionalities. Its diazine and dioxolane components can be further modified or reacted with other compounds to produce a wide range of chemical products with tailored properties.
Used in Material Science:
(Z)-bis-(4-[1,3]-dioxolan-2-yl-phenyl)diazine is utilized as a component in the development of advanced materials with unique properties. Its incorporation into polymers, for instance, can lead to materials with enhanced stability, strength, or specific interactions with other molecules, making it valuable in the creation of high-performance materials for various applications.
Used in Dye and Pigment Industry:
Due to its structural features, (Z)-bis-(4-[1,3]-dioxolan-2-yl-phenyl)diazine can be employed as a dye or pigment in the colorants industry. Its ability to absorb and reflect specific wavelengths of light can result in the production of vibrant and stable colors, which are essential in various applications such as textiles, plastics, and printing inks.
Used in Agricultural Industry:
(Z)-bis-(4-[1,3]-dioxolan-2-yl-phenyl)diazine may also find applications in the agricultural sector, potentially serving as a component in the development of new pesticides, herbicides, or fertilizers. Its chemical properties could be harnessed to target specific pests or enhance the growth and health of crops, contributing to increased agricultural productivity and sustainability.
Check Digit Verification of cas no
The CAS Registry Mumber 1509927-60-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,0,9,9,2 and 7 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1509927-60:
(9*1)+(8*5)+(7*0)+(6*9)+(5*9)+(4*2)+(3*7)+(2*6)+(1*0)=189
189 % 10 = 9
So 1509927-60-9 is a valid CAS Registry Number.
1509927-60-9Relevant academic research and scientific papers
Cage structure helps to improve the photoisomerization efficiency of azobenzene
Yuan, Tao,Wang, Zhi-Qiang,Gong, Xue-Qing,Wang, Qiaochun
supporting information, (2020/11/19)
Azobenzene (Azo) usually cannot achieve relatively high photoisomerization efficiency because of the overlap of the n-π* absorption bands between their isomers. In this work, three Azo units were integrated into a cage (AC) and adopt a nonplanar configura
Novel compounds for the prophylaxis and treatment of inflammatory bowel diseases
-
Page/Page column 5, (2010/11/25)
Novel compounds are disclosed for the prophylaxis and treatment of inflammatory bowel disease (IBD) via the administration of an effective amount in a suitable pharmaceutical dosage of agents that are active by themselves or can deliver tin the large intestine active forms of the drugs such as 5ASA or benzoxazole acetic acid or platelet activating factors. The mechanism of the release is based on bacterial cleavage of an azo linkage in the mammalian lower bowel to release the active compound(s).
Benzoxazole derivatives for the prophylaxis and treatment of inflammatory bowel diseases
-
Page/Page column 9-10, (2010/11/23)
The present invention relates to novel compounds for the prophylaxis and treatment of inflammatory bowel disease (IBD) via the administration of an effective amount in a suitable pharmaceutical dosage of agents that are active by themselves or can deliver tin the large intestine active forms of the drugs such as 5ASA or benzoxazole acetic acid or platelet activating factors. The mechanism of the release is based on bacterial cleavage of an azo linkage in the mammalian lower bowel to release the active compound(s).
One-pot synthesis of terpyridines and macrocyclization to C3-symmetric cyclosexipyridines
Masciello, Lucie,Potvin, Pierre G.
, p. 209 - 218 (2007/10/03)
Four examples of 2,6-dicinnamoylpyridines were obtained in 60-65% yields in condensations of commercially available 2,6-diacetylpyridine and benzaldehydes in 1:2 stoichiometry. At 2:1 ratios, four related 6,6″-diacetylated-4′-arylterpyridines were isolate